FibroBiologics, Inc.
FBLG
$0.35
$0.025.13%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -8.17% | -10.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.20% | -0.90% | |||
| Operating Income | -12.20% | 0.90% | |||
| Income Before Tax | -24.04% | 6.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -24.04% | 6.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -24.04% | 6.20% | |||
| EBIT | -12.20% | 0.90% | |||
| EBITDA | -12.26% | 1.07% | |||
| EPS Basic | -11.19% | 10.93% | |||
| Normalized Basic EPS | -11.14% | 10.87% | |||
| EPS Diluted | -11.19% | 10.93% | |||
| Normalized Diluted EPS | -11.14% | 10.87% | |||
| Average Basic Shares Outstanding | 11.48% | 5.35% | |||
| Average Diluted Shares Outstanding | 11.48% | 5.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||